Intelligencer - How TikTok Beat the Ban (for Now)

Columns and commentary on news, politics, business, and technology from the Intelligencer team.

Key phrases

Older messages

The Revolt of the Other Mothers

Tuesday, May 30, 2023

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer Stay informed about business, politics, technology, and where they intersect. Subscribe now

Reality Check

Saturday, May 27, 2023

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer Weekend Reader Required Reading for Political Compulsives 1. Does Eric Adams Still Think

The Scramble To House Our Busloads of Migrants

Friday, May 26, 2023

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer Stay informed about business, politics, technology, and where they intersect. Subscribe now

Twitter Will Drive Conservatives Mad — and Further Right

Thursday, May 25, 2023

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer Stay informed about business, politics, technology, and where they intersect. Subscribe now

Ron DeSantis, a Strongman Who Isn’t Dumb

Wednesday, May 24, 2023

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer Stay informed about business, politics, technology, and where they intersect. Subscribe now

You Might Also Like

How to build a “Bloomberg for X” media company

Thursday, April 25, 2024

Many companies that attempted to monetize media outlets with non-media tech products have stumbled. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Prefer to Skip Mother’s Day Emails?

Thursday, April 25, 2024

Tap a button, and you won't hear from us. The Strategist Prefer to Skip Mother's Day Emails? Mother's Day is coming up, and we understand that this can be a difficult time for some. So if

GeekWire Mid-Week Update

Wednesday, April 24, 2024

Read the top tech stories so far this week from GeekWire GeekWire Mid-Week Update Top stories so far this week After lobbying by Uber and DoorDash, new proposal would overhaul Seattle's minimum

Student Protesters Are Schooling Their Universities

Wednesday, April 24, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer student protests Student Protesters Are Schooling Their Universities Pro-Palestinian

The magic of white noise

Wednesday, April 24, 2024

Sweet dreams ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Thursday Briefing: Israel seems poised to invade Rafah

Wednesday, April 24, 2024

Also, details of the US aid package to Ukraine and Taylor Swift's new album View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 25, 2024

Feeling stressed? This doctor’s got a book on it.

Wednesday, April 24, 2024

You're invited to The Conversation's book club in May ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

ByteDance with Death

Wednesday, April 24, 2024

TikTok's Tick Tock, Calorie Restriction ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

The Rise Of Big Oil’s Zombie Pipelines

Wednesday, April 24, 2024

Big Oil is fighting to limit safety protections to expedite its build-out of experimental carbon dioxide pipelines, endangering nearby communities. While leaks from carbon dioxide pipelines have sent

How the FTC ban on non-competes could help tech companies

Wednesday, April 24, 2024

Microsoft earnings preview | 98point6 layoffs | New EV rebate program ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the potential of CAR T cell